OXON Epidemiology

OXON Epidemiology is a full-service scientific Contract Research Organization (CRO) specialising in real-world data for pre- and post-approval products via strategic, scientific and operational solutions to the biopharmaceutical and medical device industries.

Based in London, Madrid and the USA, OXON specialises in real-world data in the areas of Safety, HEOR/market access, Drug development and Marketing via:

• Multi-country field, chart review and database epidemiological studies
• Patient registries
• Risk management, PASS and Risk minimisation studies
• Statistical signal detection & analysis
• Quantitative benefit-risk analysis for CTD / PBRER
• Patient-reported outcomes
• Health economics & modelling
• Meta-analysis
• Evidence strategy

 We have an international network of clinical and world-renowned academic consultants being among OXON staff publications: Lancet (x7), JAMA (x1) and BMJ (x3).

OXON is an ENCePP centre (European Network of Centres in Pharmacoepidemiology and Pharmacovigilance) of the EMA (European Medicines Agency), where we are leading an initiative on data integration with EMA regulators and leading academic pharmacoepidemiologists.

A solid long-term alliance established with a large middle-tier global CRO allows us to successfully fulfil projects involving real-world observational, PASS, PRO and pharmacoeconomic studies in Europe, Canada, Asia, Latin America and Australia for large and medium size clients.

MARCAS: OXON EPIDEMIOLOGY